Global Glycated Albumin Assay Market Size Study & Forecast, by Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes) by End User (Hospitals & Diabetic Care Centers, Diagnostic Laboratories) and Regional Forecasts 2025-2035

The Global Glycated Albumin Assay Market is valued at approximately USD 1.19 billion in 2024 and is projected to grow at a robust CAGR of 8.90% during the forecast period 2025-2035. Glycated albumin assays are advanced diagnostic tools used to monitor short-term glycemic control, providing critical insights into blood sugar fluctuations over a period of 2–4 weeks. These assays are increasingly adopted for assessing prediabetes, managing type 1 and type 2 diabetes, and complementing traditional HbA1c measurements. The growth of the market is propelled by the escalating prevalence of diabetes worldwide, rising awareness regarding the importance of continuous glucose monitoring, and advances in assay sensitivity and specificity. Moreover, increasing healthcare expenditure, enhanced laboratory infrastructure, and the growing emphasis on early diagnosis and preventive care are significant contributors to market expansion.

The rising burden of diabetes across the globe has triggered a surge in demand for glycated albumin assays. These assays offer advantages over conventional glucose monitoring methods, particularly in cases where HbA1c readings may be unreliable due to conditions like anemia or hemoglobinopathies. According to global health statistics, the number of adults living with diabetes is projected to reach over 700 million by 2035, amplifying the need for accurate and timely diagnostics. Additionally, the proliferation of advanced assay platforms and automated testing solutions provides lucrative opportunities for market participants. Nevertheless, high assay costs and stringent regulatory frameworks may temper market growth during the forecast period 2025-2035.

The detailed segments and sub-segments included in the report are:

By Application:
• Prediabetes
• Type 1 Diabetes
• Type 2 Diabetes

By End User:
• Hospitals & Diabetic Care Centers
• Diagnostic Laboratories

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• RoE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Type 2 Diabetes Segment Expected to Dominate the Market

The type 2 diabetes segment is anticipated to dominate the glycated albumin assay market, accounting for the largest share due to the widespread prevalence of type 2 diabetes among adults. Increased awareness of early diagnosis, coupled with rising healthcare screening initiatives, has propelled adoption of these assays in clinical settings. Prediabetes monitoring is also gaining traction as healthcare providers prioritize preventive strategies, though its market share remains comparatively moderate.

Hospitals & Diabetic Care Centers Lead in Revenue Contribution

When segmented by end user, hospitals and diabetic care centers currently generate the highest revenue, benefiting from their expansive patient base and routine monitoring protocols. Diagnostic laboratories are experiencing steady growth, driven by rising demand for specialized testing services, automation, and advanced assay platforms. This delineates a market where hospitals dominate in revenue, while laboratories accelerate adoption through technology-driven enhancements.

North America dominated the market in 2025 due to a well-established healthcare ecosystem, advanced diagnostic infrastructure, and widespread awareness of diabetes management. Europe follows closely, supported by proactive government initiatives, reimbursement policies, and clinical adoption of glycated albumin assays. Asia Pacific is projected to be the fastest-growing region over the forecast period, fueled by rising diabetes prevalence, growing healthcare expenditure, and expanding laboratory networks in countries such as China and India. Latin America and the Middle East & Africa are emerging markets, driven by increasing awareness and infrastructure development in urban healthcare facilities.

Major market players included in this report are:
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Bio-Rad Laboratories
• Arkray, Inc.
• Beckman Coulter, Inc.
• Diazyme Laboratories
• EKF Diagnostics
• Tosoh Bioscience
• MedTest DX
• Randox Laboratories
• Mindray Medical International
• Diazyme, Inc.
• Diazyme Laboratories, Inc.
• Medtronic

Global Glycated Albumin Assay Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more